Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huadong Medicine is a Chinese leader in pharmaceuticals, medical aesthetics, innovative drugs, and biologics with a global pipeline of over a dozen innovative drugs, including commercial and late-stage clinical programs for metabolic diseases, oncology (notably ADCs), and autoimmune conditions. The company leads in diabetes and obesity treatment, contributes to pioneering antibody-drug conjugate (ADC) development (e.g., ELAHERE in ovarian cancer), and is advancing next-generation small molecules, biologics, and topical therapies for chronic diseases and aesthetics[2][4][6].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Huadong Medical Beauty Biotechnology.